Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1302

1.

Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.

Bhaskar K, Krishna Mohan C, Lingam M, Jagan Mohan S, Venkateswarlu V, Madhusudan Rao Y, Bhaskar K, Anbu J, Ravichandran V.

Drug Dev Ind Pharm. 2009 Jan;35(1):98-113. doi: 10.1080/03639040802192822 .

PMID:
18665979
2.

Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization.

Bhaskar K, Krishna Mohan C, Lingam M, Prabhakar Reddy V, Venkateswarlu V, Madhusudan Rao Y.

Drug Dev Ind Pharm. 2008 Jul;34(7):719-25. doi: 10.1080/03639040701842485 .

PMID:
18612912
3.

Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.

Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM.

Lipids Health Dis. 2009 Feb 26;8:6. doi: 10.1186/1476-511X-8-6.

5.

Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.

Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV.

Int J Pharm. 2007 Apr 20;335(1-2):167-75. Epub 2006 Nov 3.

PMID:
17161566
6.

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.

Uner M, Wissing SA, Yener G, Müller RH.

Pharmazie. 2005 Aug;60(8):577-82.

PMID:
16124399
7.
8.
9.

Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.

Pathak P, Nagarsenker M.

AAPS PharmSciTech. 2009;10(3):985-92. doi: 10.1208/s12249-009-9287-1. Epub 2009 Jul 30.

10.

Preparation and characterization of nitrendipine solid lipid nanoparticles.

Manjunath K, Venkateswarlu V, Hussain A.

Pharmazie. 2011 Mar;66(3):178-86.

PMID:
21553647
11.
12.

Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery.

Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y.

Drug Deliv. 2005 Jul-Aug;12(4):207-15.

PMID:
16036715
14.

Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).

Fang JY, Fang CL, Liu CH, Su YH.

Eur J Pharm Biopharm. 2008 Oct;70(2):633-40. doi: 10.1016/j.ejpb.2008.05.008. Epub 2008 Jun 5.

PMID:
18577447
15.

Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.

Souto EB, Wissing SA, Barbosa CM, Müller RH.

Int J Pharm. 2004 Jun 18;278(1):71-7.

PMID:
15158950
16.

Preparation and characteristics of monostearin nanostructured lipid carriers.

Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S.

Int J Pharm. 2006 May 11;314(1):83-9. Epub 2006 Mar 24.

PMID:
16563671
17.

Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.

Souto EB, Wissing SA, Barbosa CM, Müller RH.

Eur J Pharm Biopharm. 2004 Jul;58(1):83-90.

PMID:
15207541
18.

Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.

Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X.

Int J Pharm. 2007 Jan 10;328(2):191-5. Epub 2006 Aug 15.

PMID:
16978810
19.

Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.

Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X.

Int J Pharm. 2010 Jul 15;394(1-2):179-85. doi: 10.1016/j.ijpharm.2010.05.005. Epub 2010 May 13.

PMID:
20471464
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk